Aparajita Singh1, Kristin Englund. Show Affiliations » 1. Division of Hospital Medicine, University of California San Francisco, USA.
Abstract
Mesh: See more » AgedCost-Benefit AnalysisHerpes Zoster/immunologyHerpes Zoster/prevention & controlHerpes Zoster Vaccine/adverse effectsHerpes Zoster Vaccine/economicsHerpes Zoster Vaccine/immunologyHerpesvirus 3, Human/immunologyHumansUnited StatesVaccination
Substances: See more » Herpes Zoster Vaccine
Year: 2009 PMID: 19122110 DOI: 10.3949/ccjm.75a.08046
Source DB: PubMed Journal: Cleve Clin J Med ISSN: 0891-1150 Impact factor: 2.321